This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Free Reports

After Exubera, Uncertainty Reigns

10/22/07 - 04:01 PM EDT

Pfizer's decision to drop inhaled insulin could dim the prospects for competing products.

Hot Art From the Arctic

10/19/07 - 09:47 AM EDT

Inuit prints from northern Canada offer a beautiful -- and affordable -- investment.

Can Good Health Last for Medical IPOs?

09/11/07 - 02:20 PM EDT

The first part of the year was solid for new biotechs and health stocks.

Challenges Persist for Glaxo

08/22/07 - 04:43 PM EDT

Fans say the company is too big to fail, but it's also too big to grow much without developing more hits.

J&J's Risperdal Gets New Uses

08/22/07 - 04:35 PM EDT

The drug is approved by the FDA for younger patients.

Pfizer Finds New CFO

08/22/07 - 11:18 AM EDT

Frank D'Amelio will join the company from Alcatel-Lucent.

FDA Approves Novartis Osteoporosis Drug

08/20/07 - 05:19 PM EDT

Reclast is a once-a-year treatment.

Glaxo Drug Gets Black Box

08/14/07 - 05:38 PM EDT

Avandia will carry a new warning.

Wyeth Whacked on Drug Setbacks

08/10/07 - 01:49 PM EDT

It gets bad news from the FDA and pulls a hepatitis C drug candidate.

One Giant Leap for MannKind

08/09/07 - 05:48 PM EDT

The company will sell $350 million in debt, warrants and stock.

Page 3 of 147
Top Rated Stocks Top Rated Funds Top Rated ETFs